Experts discuss the challenges of managing atopic dermatitis in real-world clinical practice, highlighting access barriers due to insurance disparities, the need for creative solutions to provide ...

Red, itchy, and scaly skin from atopic dermatitis and eczema can be uncomfortable, confusing, and all too familiar. These chronic (meaning they can last a long time) inflammatory conditions can appear ...

Atopic dermatitis is a chronic inflammatory skin disease that causes extreme dryness, itchy rashes, scaly patches, and blisters that can ooze, crust, and flake. It affects people of all ages, all over ...

Atopic dermatitis, the most common form of eczema, affects millions of Americans with its hallmark symptoms of dry, itchy, and inflamed skin. While this chronic condition can impact individuals across ...

Atopic dermatitis, or eczema, can make your skin itchy, raw, and sensitive. To relieve the discomfort and reduce flare-ups, follow these tips from board-certified dermatologists. 1. Moisturize after ...

A group of dermatologists and dermatology students studied why atopic dermatitis may be related to certain cardiovascular diseases, neuropsychiatric diseases, autoimmune diseases, and obesity. It’s ...

But when you add being Black to the equation — and the racism and other forms of bias that come with it — those negative feelings can intensify. It’s common for Black people with atopic dermatitis to ...

Atopic dermatitis, the most common type of eczema, can be relentless—bringing daily itch, pain, and emotional strain. But ...

Please provide your email address to receive an email when new articles are posted on . Samples of skin microbiota in infants showed lower levels of natural moisturizing in patients who later ...

throughout childhood. However, the symptoms had been fairly well managed with a consistent moisturizing routine — until she hit her preteen years. “I remember going from having very beautiful skin to ...

Discover some of the new atopic dermatitis treatments in clinical development that could overcome existing challenges in the ...

TRexBio Doses First Patient with Moderate-to-Severe Atopic Dermatitis in Phase 1b Clinical Trial of TRB-061, a TNFR2 Agonist ...